2 transcripts
ITCI
Earnings call transcript
NASDAQ
2024 Q1
7 May 24
dose study and a positron emission tomography study are both ongoing.
Finally, last year, we introduced a portfolio of nonvaluingenic psychedelic
ITCI
Earnings call transcript
NASDAQ
2023 Q4
22 Feb 24
development programs include ITI for opioid use disorder in pain for which a multiple ascending dose study and a positron emission tomography study
- Prev
- 1
- Next